NEUROCENTRIA, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neurocentria.com
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder
- Conditions
- ADHD
- Interventions
- Drug: NRCT-101SR, NRCT-202XR
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06673368
- Locations
- 🇺🇸
Accel Research Site-Maitland Clinical Research Unit, Maitland, Florida, United States
🇺🇸iResearch Atlanta, Decatur, Georgia, United States
🇺🇸CenExel iRS - iResearch Savannah, Savannah, Georgia, United States
Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06215144
- Locations
- 🇺🇸
Advanced Research Center, Inc, Anaheim, California, United States
🇺🇸Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States
🇺🇸Accel Research Sites Network - Maitland, Maitland, Florida, United States
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 223
- Registration Number
- NCT05683249
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Garden Grove, California, United States
🇺🇸Accel Research Sites, Maitland, Florida, United States
🇺🇸Miami Dade Medical Research Institute, Miami, Florida, United States
Comparison of MMFS Dosages in Older Adults
- Conditions
- AnxietyDepressionCognitive ImpairmentSleep Quality
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03601169
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Efficacy and Safety of MMFS in Early AD
- Conditions
- Alzheimer Disease
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03531684
- Locations
- 🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States